FI CONNECT
GLOBAL
Search
Select Country
LIFE AT FI GROUP
CONTACT
Combining Venture Capital and Innovation Funding in Europe and the UK
Help us to share it on
About this publication
Published Date
01-09-2025
Reading Time
12 min.
Author
Fraser Richardson
Not to be missed
4 days ago
UK-US pharmaceuticals deal: implications for biotech funding and R&D tax
5 days ago
FI Group UK Moves to 40 Leadenhall Street, London, EC3A 2BJ
10 days ago
From ‘File and Hope’ To Pre-Assessment: R&D Tax Relief In The Age Of Advance Assurance
10 days ago
VCT Relief Cut, VCT Limits Up: What Rachel Reeves Just Changed For Scale Ups
10 days ago
2025 Budget: Why Innovation Capital Just Got More Expensive for UK Scale Ups
All Publications
Related
Posts
a year ago
Consumable Costs in R&D Tax Credit Claims
2 months ago
R&D tax relief in 2025: why in-year claiming is becoming essential
3 months ago
Merck shelves £1bn UK expansion: what it means for life sciences CFOs, and how to respond
4 months ago
Top 5 Reasons HMRC Challenges R&D Tax Credit Claims and How to Avoid Them
5 months ago
Venture Capital and R&D Investment
4 months ago
UK R&D Spending Decline: Impact on Growth and Innovation
a year ago
The Risks of Using AI in R&D Tax Claims: A Cautionary Tale
2 years ago
What is RDEC: A Comprehensive Guide to Research and Development Expenditure Credit
2 years ago
R&D Tax Credit Claim Deadline and How Far Back you Can Claim it
2 years ago
A Guide to R&D Capital Allowances
BACK TO TOP
Certifications
Previous slide
Next slide
FI Group UK
@FI Group by EPSA Copyright 2025
Policy Privacy
Term of use
Cookie Policy
Compliance FI Group
FI Group UK
@FI Group by EPSA Copyright 2025
Policy Privacy
Term of use
Cookie Policy
Compliance FI Group